Pharmaceutical regulatory data, drug approvals & compliance tracking
Home › Compliance › Gmp
This page provides comprehensive data and analytics for gmp compliance guide. Our database is updated regularly to ensure accuracy and relevance. Our methodology combines automated data collection with expert curation to ensure high-quality, reliable information. Each data point is verified against multiple sources before publication.
Data accuracy is our top priority. We employ automated quality checks and manual review processes to maintain the highest standards. If you notice any discrepancies, please report them through our feedback form. Industry experts recommend monitoring these metrics on a monthly basis to stay ahead of market shifts. Our data shows significant movement in several key indicators over the past quarter.
All data on FDA News is provided for informational purposes. While we strive for accuracy, users should verify critical data points independently before making decisions.
| Requirement | Category | Deadline | Penalty | Reference |
|---|---|---|---|---|
| Annual registration | Mandatory | Dec 31 | $15,000 | 21 CFR 207 |
| Adverse event reporting | Mandatory | 15 days | Warning letter | 21 CFR 314 |
| Label review | Pre-market | Before launch | Seizure | 21 CFR 201 |
| GMP audit | Every 2 years | Ongoing | Import alert | 21 CFR 211 |
| Record keeping | Mandatory | Ongoing | $10,000/day | 21 CFR 211 |
The complete dataset for this page is available in machine-readable JSON for developers and data pipelines — direct API endpoint, no auth, no page rendering required: https://fdanews.online/api/dataset/export?token=973929e6862dce99b146fa381e04c960Full Data Export
